Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...
We are transitioning into real-world AI: an evolution from treating AI purely as a knowledge retrieval system to AI acting as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback